NCT05923112
- Conditions
- Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Pfizer Tokyo, Japan
Clinical trial condition
Leukemia, Lymphoid
Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.
3,018 public trials
549 recruiting studies
Leukemia, Lymphoid trial results
NCT06787131
- Conditions
- Chronic Disease, Disease Attributes, Healthy, +14 more
- Locations
-
- Scientia Clinical Research Sydney, Randwick NSW, Australia
NCT04178317
- Conditions
- Cancer, Chronic Lymphocytic Leukemia (CLL), Chronic Disease, Disease Attributes, +14 more
- Locations
-
- Inje University - Busan Paik Hospital /ID# 233882 Busan, Busan Gwang Yeogsi, South Korea
- Pusan National University Hospital /ID# 216850 Busan, Busan Gwang Yeogsi, South Korea
- Kyungpook National University Hospital /ID# 233884 Daegu, Daegu Gwang Yeogsi, South Korea
- The catholic university of korea st. Paul's hospital /ID# 238907 Seoul, Gyeonggido, South Korea
NCT03898128
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Irst Irccs Meldola (FC), FC, Italy
- AUSL Romagna Ravenna, RA, Italy
- Azienda ULSS2 Marca Trevigiana Treviso, TV, Italy
- ULSS 3 Serenissima Mestre, Venezia, Italy
NCT05687032
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Guangzhou First People's Hospital Guangzhou, Guangdong, China
- NanFang Hospital of Southern Medical University Guangzhou, Guangdong, China
NCT04008706
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Research Site Chandler, Arizona, United States
- Research Site Long Beach, California, United States
- Research Site Redlands, California, United States
- Research Site Whittier, California, United States
Completed
Phase II Trial GA101 Inbrutinib B CLL
NCT02666898
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
- Locations
-
- Sponsor FILO Tours, France
NCT02568553
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- National Cancer Center Hospital East /ID# 265970 Kashiwa-shi, Chiba, Japan
NCT02588651
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Angioimmunoblastic T-cell Lymphoma, Enteropathy Associated T-cell Lymphoma, +22 more
- Locations
-
- Wayne State University, Karmanos Cancer Institute Detroit, Michigan, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States